SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.40
+2.28%Nov 3, 2026, 12:00 UTC
Sotera Health Co reaffirmed its full-year 2026 outlook for constant-currency net revenue growth of 5.25%–6.75% and Adjusted EBITDA growth of 5.75%–7.25%.
Source:Nov 3, 2026, 12:00 UTC
Sotera Health Co reported third-quarter 2026 net revenues up 4.4% year over year, net income of $58 million, Adjusted EBITDA up 3.9%, and Adjusted EPS of $0.29, up 12%.
Source:Oct 21, 2026, 11:00 UTC
Sotera Health announced that it plans to release its third-quarter 2026 financial results before the market opens on November 3, 2026.
Source:Aug 20, 2026, 07:24 UTC
Bank of America Corp DE increased its stake in Sotera Health Company by 332.7% during the quarter, acquiring an additional 991,620 shares, according to a Form 13F filing.
Source:Aug 14, 2026, 00:00 UTC
James C. Neary resigned as Class I director of Sotera Health Co, effective August 13, 2026.
Aug 6, 2026, 00:00 UTC
Sotera Health Co reported Q2 2026 financial results with revenue of $321.4 million, net income of $53.6 million, and diluted EPS of $0.19.